Cited by 2,650Acute Ischemic Stroke ManagementCerebrovascular and Carotid Artery DiseasesCardiovascular and Diving-Related Complications

The DOI matches its Crossref record, with a small difference in title or year; 1,217 of the 1,217 references it cites were found in a registry or an index.

Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

Open access

Abstract

The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of stroke among individuals who have not previously experienced a stroke or transient ischemic attack. Evidence-based recommendations are included for the control of risk factors, interventional approaches to atherosclerotic disease of the cervicocephalic circulation, and antithrombotic treatments for preventing thrombotic and thromboembolic stroke. Further recommendations are provided for genetic and pharmacogenetic testing and for the prevention of stroke in a variety of other specific circumstances, including sickle cell disease and patent foramen ovale.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/str.0000000000000046

Cites

1217 of 1217 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 1,217 references

Research works printed but not linked: 7

  1. Tournier-Lasserve E, Joutel A, Chabriat H, Vahedi K, Nagy T, Ducros A, Nibbio A, Verin M, Mas JL, Davous P, Ducrocq, Levasseur M, Dubois B, Lyoncaen O, Ragno M, Hutchinson M, Burkhard P, Julien J, Viader F, Burgunder JM, Iba-Zizen MT, Bousser MG. CADASIL Clinical phenotypes and genetic data in 15 unrelated families. Neurology. 1995;45(4 Suppl 4):A273.
  2. Desnick R, Ioannou Y, Eng C. Alpha-galactosidase A deficiency: Fabry disease. , Scriver CR, Beauder AL, Sly WS, Childs B, Valle D, Kinzler KW, Vogelstein B, eds. In: The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 2001:3733–3774.
  3. Ortel T. Genetics of coagulation disorders. , Alberts M, ed. In: Genetics of Cerebrovascular Disease. Armonk, NY: Futura Publishing; 1999:129–156.
  4. Institute of Medicine. Dietary Reference Intakes: Water, Potassium, Sodium, Chloride, and Sulfate. Washington, DC: National Academies Press; 2004.
  5. Lal BK, Meschia JF, Brott TG. CREST-2: Guiding treatments for asymptomatic carotid disease. Endovascular Today. September 2013:73–76.
  6. Adams RJ. Neurologic complications. , Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. In: Sickle Cell Disease: Basic Principals and Clinical Practice. New York, NY: Raven Press; 1994;599–621.
  7. National Institutes of Health. Management of Sickle Cell Disease. Bethesda, MD: National Institutes of Health; 2002. Publication No. 02-2117.

Cited by

Sorted by citations

Metadata

Authors
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., Goldstein, L. B., Greenberg, S. M., Horvath, S. E., Iadecola, C., Jauch, E. C., Moore, W. S., & Wilson, J. A.
Affiliations
American Heart Association (US)
Venue
Stroke
Published
2014-12
Volume
45
Issue
12
Pages
3754-3832
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2114635452
Cited by
2,650
References
1,217
Citations by year
2026: 44 · 2025: 89 · 2024: 129 · 2023: 128 · 2022: 154 · 2021: 221 · 2020: 220 · 2019: 191 · 2018: 213 · 2017: 220 · 2016: 227 · 2015: 224 · 2014: 189
FWCI
215.43
Type
journal article
Language
en
Open access
Locations
  • Stroke (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • Sanofi
  • Brigham and Women's Hospital
  • Biogen
  • University of Miami
  • Wake Forest University
  • Rush University
  • University of Texas Health Science Center at Houston
  • Amarin Corporation
  • York University
  • IC Design Education Center
  • Novo Nordisk
  • National Institutes of Health (5u01ns069208-04)
  • Claude Pepper Older Americans Independence Center, Wake Forest School of Medicine
  • Leonard M. Miller School of Medicine
  • Abbott Vascular
  • National Heart, Lung, and Blood Institute
  • National Institute of Neurological Disorders and Stroke (R01NS034179, U01-NS069208)
  • Daiichi Sankyo Europe
Topics
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
Keywords
stroke prevention, primary prevention, stroke risk factors, atherosclerosis, cerebrovascular disease, antithrombotic therapy, thromboembolic stroke, thrombotic stroke, genetic testing, pharmacogenetic testing, sickle cell disease, patent foramen ovale
MeSH terms
American Heart Association, Humans, Primary Prevention, Risk Factors, United States, Evidence-Based Medicine, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review